Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-03-20
2007-03-20
Carlson, Karen Cochrane (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S399000
Reexamination Certificate
active
11033358
ABSTRACT:
A compaction assay measuring the viscoelasticity of sputum samples of patients subject to respiratory disease is provided. This assay is useful in determining the therapeutic efficacy of DNase, antibiotic and other respiratory disease treatments in improving lung function.
REFERENCES:
patent: 3914985 (1975-10-01), von Behrens
patent: 4072045 (1978-02-01), Kopito
patent: 5364763 (1994-11-01), Kacian
patent: 0285439 (1994-09-01), None
patent: 460868 (1975-09-01), None
Aiken et al., “Recombinant Human DNase Inhalation in Normal Subjects and Patients with Cystic Fibrosis”Journal of the American Medical Assn.267(14):1947-1951 (Apr. 1992).
Boat et al., “Cystic Fibrosis”The Metabolic Basis of Inherited Disease, Scriver et al., McGraw Hill, Chapter 108, pp. 2646-2680 (1989).
Clifton et al., “Pancreatic Deoxyribonuclease (Dornase) Aerosol in Treatment of Bronchopulmonary Complications and Tracheitis Sicca”Cancer14:414-420 (Mar.-Apr. 1961).
“Database WPI, Week 7541, Derwent Publications Ltd., London, GB; AN 75-L1806W and SU A 460 868 (Work Hygiene Profes)” (Abstract only) (1975).
Dulfano et al., “Sputum Viscoelasticity in Chronic Bronchitis”Am. Rev. Respir. Dis.104:88-98 (1971).
George et al., “Pseudomonas Infections in Cystic Fibrosis”Archives of Dis. Childhood62:438-439 (1987).
Hubbard et al., “A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis”New England J. of Medicine26(12):812-815 (Mar. 1992).
Karem et al., “The Relation Between Genotype and Phenotype in Cystic Fibrosis—Analysis of the Most Common Mutation”New England J. of Medicine323(22):1517-1522 (Nov. 1990).
King, M., “The Role of Mucus Viscoelasticity in Cough Clearance”Biorheology24:589-597 (1987).
Lethem, M. et al., “The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum”Eur. Respir. J.3:19-23 (1990).
Lopez-Vidriero et al., “Respiratory tract fluid—chemical and physical properties of airway mucus”Eur. J. Respir. Dis.61(Suppl. 110):21-26 (1980).
Matthews et al., “Studies on Pulmonary Secretions”Am. Rev. Respir. Dis.88:199-204 (1963).
Montalembert et al., “Antimicrobial Treatment in Cystic Fibrosis”Ann. Pediatric.38(8):523-528 (1991).
Mulherin et al., “Aminoglycoside Induced Ototoxicity in Patients with Cystic Fibrosis”Irish Journal of Medical Science160(6):173-175 (Jun. 1991).
Mulherin et al., “Cystic Fibrosis in Adolescents and Adults”Dig. Dis.10(1):29-37 (1992).
Nelson et al., “Decomposition of Expoploysaccharide Slime by a Bacteriophage Enzyme”Water Res.22:1185-1188 (1988).
Picot et al., “Pus, deoxyribonucleic acid, and sputum viscosity”Thorax33:235-242 (1978).
Raskin, Philip, “Bronchospasm After Inhalation of Pancreatic Dornase”Am. Rev. of Respiratory Disease98:697-698 (1968).
Reid, L., “Rheology-Relation to the Composition of Sputum”Scandinavian J. of Respiratory Diseases, Munkgaard International Publishers vol. 103:27-35 (1974).
Rosenbluth et al., “Influence of Mist Tent Therapy on Sputum Viscosity and Water Content in Cystic Fibrosis”Arch. of Dis. Childhood49:606-610 (1974).
Shak et al., “Recombinant Human DNase I Reduces the Viscosity of Cystic Fibrosis Sputum”Proc. Natl. Acad. Sci. USA87(23):9188-9192 (Dec. 1990).
Thornton et al., “Mucus glycoproteins from cystic fibrotic sputum”Biochemical Journal276:667-675 (1991).
Vasconcellos, C. et al., “Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin”Science263:969-971 (1994).
Welsh et al., “Cystic Fibrosis”J. Clin. Invest.80:1523-1526 (Dec. 1987).
Yeates, D., “Mucus Rheology”The Lung: Scientific Foundations, R.G. Crystal et al., New York, NY:Raven Press pp. 197-203 (1991).
Zach et al., “Chest Physiotherapy—The Mechanical Approach to Antiinfective Therapy in Cystic Fibrosis”Infection15(5):381-384 (1987).
Daugherty Ann L.
Mrsny Randy J.
Patapoff Thomas W.
Carlson Karen Cochrane
Evans David W.
Genentech Inc.
LandOfFree
Compaction assay for assessment of respiratory disease therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compaction assay for assessment of respiratory disease therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compaction assay for assessment of respiratory disease therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3742606